These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31214178)

  • 1. The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.
    Weed DT; Zilio S; Reis IM; Sargi Z; Abouyared M; Gomez-Fernandez CR; Civantos FJ; Rodriguez CP; Serafini P
    Front Immunol; 2019; 10():1206. PubMed ID: 31214178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
    Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
    Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
    Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L
    Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.
    Ryan N; Anderson K; Volpedo G; Hamza O; Varikuti S; Satoskar AR; Oghumu S
    Int J Cancer; 2020 Mar; 146(6):1717-1729. PubMed ID: 31709529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic Approaches to Head and Neck Cancer.
    Nasser H; St John M
    Crit Rev Oncog; 2018; 23(3-4):161-171. PubMed ID: 30311572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma.
    Califano JA; Khan Z; Noonan KA; Rudraraju L; Zhang Z; Wang H; Goodman S; Gourin CG; Ha PK; Fakhry C; Saunders J; Levine M; Tang M; Neuner G; Richmon JD; Blanco R; Agrawal N; Koch WM; Marur S; Weed DT; Serafini P; Borrello I
    Clin Cancer Res; 2015 Jan; 21(1):30-8. PubMed ID: 25564570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes.
    Affolter A; Liebel K; Tengler L; Seiz E; Tiedtke M; Azhakesan A; Schütz J; Theodoraki MN; Kern J; Ruder AM; Fleckenstein J; Weis CA; Bieback K; Kramer B; Lammert A; Scherl C; Rotter N; Ludwig S
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD‑L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling.
    Zheng A; Li F; Chen F; Zuo J; Wang L; Wang Y; Chen S; Xiao B; Tao Z
    Oncol Rep; 2019 May; 41(5):2833-2843. PubMed ID: 30864729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.
    Tan YS; Sansanaphongpricha K; Xie Y; Donnelly CR; Luo X; Heath BR; Zhao X; Bellile E; Hu H; Chen H; Polverini PJ; Chen Q; Young S; Carey TE; Nör JE; Ferris RL; Wolf GT; Sun D; Lei YL
    Clin Cancer Res; 2018 Sep; 24(17):4242-4255. PubMed ID: 29769207
    [No Abstract]   [Full Text] [Related]  

  • 10. Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma.
    Xu S; Wang H; Zhu Y; Han Y; Liu L; Zhang X; Hu J; Zhang W; Duan S; Deng J; Zhang Z; Liu S
    Int J Oral Sci; 2024 Jul; 16(1):47. PubMed ID: 38945975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
    Ma H; Yang W; Zhang L; Liu S; Zhao M; Zhou G; Wang L; Jin S; Zhang Z; Hu J
    Br J Cancer; 2019 Feb; 120(3):317-330. PubMed ID: 30555157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma.
    Gross NE; Zhang Z; Mitchell JT; Charmsaz S; Hernandez AG; Coyne EM; Shin SM; Vargas Carvajal DC; Sidiropoulos DN; Cho Y; Mo G; Yuan X; Cannon C; Suresh Babu J; Lyman MR; Armstrong T; Kagohara LT; Bever KM; Le DT; Jaffee EM; Fertig EJ; Ho WJ
    JCI Insight; 2024 Aug; 9(18):. PubMed ID: 39106104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized cancer vaccination in head and neck cancer.
    Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
    Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
    Solomon B; Young RJ; Rischin D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.
    Wang C; Zainal NS; Chai SJ; Dickie J; Gan CP; Zulaziz N; Lye BKW; Sutavani RV; Ottensmeier CH; King EV; Abraham MT; Ismail SMB; Lau SH; Kallarakkal TG; Mun KS; Zain RB; Abdul Rahman ZA; Thomas GJ; Cheong SC; Savelyeva N; Lim KP
    Front Immunol; 2021; 12():763086. PubMed ID: 34733290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
    Tsai MS; Chen WC; Lu CH; Chen MF
    Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells in head and neck squamous cell carcinoma.
    He JY; Huo FY; Tang HC; Liu B; Bu LL
    Int Rev Cell Mol Biol; 2023; 375():33-92. PubMed ID: 36967154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
    Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.